Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Carmen, Fava"'
Autor:
Pietro Poggio, Stefania Rocca, Federica Fusella, Roberta Ferretti, Ugo Ala, Flora D’Anna, Emilia Giugliano, Cristina Panuzzo, Diletta Fontana, Valeria Palumbo, Giovanna Carrà, Daniela Taverna, Carlo Gambacorti-Passerini, Giuseppe Saglio, Carmen Fava, Rocco Piazza, Alessandro Morotti, Francesca Orso, Mara Brancaccio
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia. Patients
Externí odkaz:
https://doaj.org/article/6c827363c8c04882b2a5e5aa1fda4491
Autor:
Marianna De Muro, Annelot Julia Janssen, Sergio Amadori, Paolo de Fabritiis, Dante Sabatino, Pasquale Niscola, Lorenza Torti, Malgorzata Monika Trawinska, Cristiano Tesei, Felice Bombaci, Mario Tarricone, Monica Bocchia, Carmen Fava, Sara Galimberti, Alessandra Iurlo, Luigia Luciano, Elisabetta Abruzzese
Publikováno v:
Therapeutic Advances in Hematology, Vol 14 (2023)
Background: Hematological patients are a highly vulnerable population with an increased risk of developing severe COVID-19 symptoms due to their immunocompromised status. COVID-19 has proven to cause serious mental health issues, such as stress, anxi
Externí odkaz:
https://doaj.org/article/af627156801d40d49d02c8981f132558
Autor:
Giovanni Paolo Maria Zambrotta, Sarit Assouline, Franck E. Nicolini, Elisabetta Abruzzese, Ester Pungolino, Maria Cristina Miggiano, Chiara Elena, Alberto Alvarez Larran, Ana Triguero Moreno, Alessandra Iurlo, Cristina Bucelli, Francesca Lunghi, Isabella Capodanno, Margherita Maffioli, Sara Galimberti, Giovanni Caocci, Fabio Stagno, Susanne Saussele, Carmen Fava, Philipp Le Coutre, Massimiliano Bonifacio, Veronica Guglielmana, Federica Colombo, Laura Antolinni, Carlo Gambacorti-Passerini
Publikováno v:
HemaSphere, Vol 7, p e68411a2 (2023)
Externí odkaz:
https://doaj.org/article/b92efaff02264a589e977952f546a4bb
Autor:
Massimo Breccia, Antonella Russo Rossi, Valentina Giai, Bruno Martino, Carmen Fava, Mario Annunziata, Elisabetta Abruzzese, Gianni Binotto, Claudia Baratè, Aurelio Pio Nardozza, Alessandra Misto, Paola Coco, Valeria Calafiore, Maria Cristina Carraro, Federica Cattina, Francesco Cavazzini, Maria Teresa Corsetti, Lara Crucitti, Monica Crugnola, Paolo Ditonno, Ambra DI Veroli, Anna Ermacora, Felicetto Ferrara, Angelo Genua, Antonella Gozzini, Stefana Impera, Alessandra Iurlo, Luciano Levato, Luigiana Luciano, Maria Cristina Miggiano, Marco De Gobbi, Marco Santoro, Barbara Scappini, Anna Rita Scortechini, Andrea Patriarca, Serena Rosati, Sabina Russo, Rosaria Sancetta, Grazia Sanpaolo, Teresa Maria Santeramo, Silvia Sibilla, Federica Sorà, Paolo Sportoletti, Fabio Stagno, Elena Trabacchi, Fausto Castagnetti
Publikováno v:
HemaSphere, Vol 7, p e55133e1 (2023)
Externí odkaz:
https://doaj.org/article/7ea0bb7830224451ba8d9aae8fc0796c
Autor:
Barbara Izzo, Fabrizio Quarantelli, Ciro Del Prete, Alessandra Potenza, Santa Errichiello, Roberta Visconti, Alessandra Galdiero, Angelo Zanniti, Ida Pisano, Mariangela Capone, Giuliano Pennacchio, Manuel De Marco, Maurizio Capuozzo, Claudia Venturi, Emanuela Ottaviani, Clara Bono, Francesca Guerrini, Michael Bates, Grace Macaulay, Tran Tran, Jessica Dosanjh, Krupa Shridar, Enrico Gottardi, Emilia Giugliano, Alice Danzero, Paola Berchialla, Carmen Fava
Publikováno v:
HemaSphere, Vol 7, p e10742d3 (2023)
Externí odkaz:
https://doaj.org/article/0247ba51337c48a199204cb392351964
Autor:
Valentina Bonuomo, Marco Armenio, Daniela Cilloni, Federico Itri, Monia Marchetti, Selene Grano, Carmen Fava
Publikováno v:
HemaSphere, Vol 7, p e70865df (2023)
Externí odkaz:
https://doaj.org/article/0a18155ca812459383f8e5cc787da3c3
Autor:
Mohammad Houshmand, Nicoletta Vitale, Francesca Orso, Alessandro Cignetti, Ivan Molineris, Valentina Gaidano, Stefano Sainas, Marta Giorgis, Donatella Boschi, Carmen Fava, Alice Passoni, Marta Gai, Massimo Geuna, Federica Sora, Alessandra Iurlo, Elisabetta Abruzzese, Massimo Breccia, Olga Mulas, Giovanni Caocci, Fausto Castagnetti, Daniela Taverna, Salvatore Oliviero, Fabrizio Pane, Marco Lucio Lolli, Paola Circosta, Giuseppe Saglio
Publikováno v:
Cell Death and Disease, Vol 13, Iss 6, Pp 1-13 (2022)
Abstract The development of different generations of BCR-ABL1 tyrosine kinase inhibitors (TKIs) has led to the high overall survival of chronic myeloid leukemia (CML) patients. However, there are CML patients who show resistance to TKI therapy and ar
Externí odkaz:
https://doaj.org/article/8b9664dc6202406c8f68c1be24352acf
Autor:
Paola Pacelli, Adele Santoni, Anna Sicuranza, Elisabetta Abruzzese, Valentina Giai, Monica Crugnola, Mario Annunziata, Sara Galimberti, Alessandra Iurlo, Luigiana Luciano, Federica Sorà, Carmen Fava, Elena Bestoso, Cristina Marzano, Alessandra Cartocci, Marzia Defina, Vincenzo Sammartano, Emanuele Cencini, Donatella Raspadori, Monica Bocchia
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: In chronic myeloid leukemia (CML), about half of the patients achieving a deep and stable molecular response with tyrosine kinase inhibitors (TKIs) may discontinue TKI treatment without disease recurrence. As such, treatment-free remiss
Externí odkaz:
https://doaj.org/article/64607df57a6045d099d42d4a7f4a8486
Autor:
Alessandra Iurlo, Daniele Cattaneo, Silvia Artuso, Dario Consonni, Elisabetta Abruzzese, Gianni Binotto, Monica Bocchia, Massimiliano Bonifacio, Fausto Castagnetti, Sara Galimberti, Antonella Gozzini, Miriam Iezza, Roberto Latagliata, Luigiana Luciano, Alessandro Maggi, Maria Cristina Miggiano, Patrizia Pregno, Giovanna Rege-Cambrin, Sabina Russo, Anna Rita Scortechini, Agostino Tafuri, Mario Tiribelli, Carmen Fava, Gianantonio Rosti, Robin Foa, Massimo Breccia, Giuseppe Saglio
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Treatment-free remission (TFR) has become a primary therapeutic goal in CML and is also considered feasible by international guidelines. TKIs dose reduction is often used in real-life practice to reduce adverse events, although its impact on TFR is s
Externí odkaz:
https://doaj.org/article/65c0695e402745059fa9fbd7d9d31204
Autor:
Anna Sicuranza, Ilaria Ferrigno, Elisabetta Abruzzese, Alessandra Iurlo, Sara Galimberti, Antonella Gozzini, Luigiana Luciano, Fabio Stagno, Antonella Russo Rossi, Nicola Sgherza, Daniele Cattaneo, Corrado Zuanelli Brambilla, Cristina Marzano, Carmen Fava, Olga Mulas, Emanuele Cencini, Adele Santoni, Vincenzo Sammartano, Alessandro Gozzetti, Luca Puccetti, Monica Bocchia
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tyrosine kinase inhibitors (TKI) may offer a normal life expectancy to Chronic Myeloid Leukemia (CML) patients. However, a higher than expected incidence of arterial occlusive events (AOEs) was observed during treatment with nilotinib. We previously
Externí odkaz:
https://doaj.org/article/5ddf4f9f79054a4e8cbdd98e58692599